MBS items are now available for Familial Hypercholesterolemia (FH) genetic testing of affected individuals and cascade testing of their first and second degree relatives. The move is likely to help lipid clinics identify the many asymptomatic family members with FH who will benefit from early initiation of lipid lowering therapy, according to atherosclerosis specialists. “The ...
Lipid experts welcome Medicare funding for FH cascade testing
By Michael Woodhead
20 May 2020